Therefore, pharmacologically increasing DJ-1 protein expression or its activity using small molecules, such as the clinically used 4-phenyl butyric acid (PBA) [40] that also reduces insulin resistance in the ob/ob mouse model [41], represents a possible approach for reducing both insulin resistance and beta cell death in the future. The gene discussed is PARK7; the disease is Insulin resistance.